Remove Bioavailability Remove Containment Remove Drug Delivery Remove Gene Silencing
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. Attendees will understand best practices for novel drug delivery design and development. The key active ingredient, cyclosporine, functions as a selective immunomodulatory drug.